.png)
Navigating xerostomia, or dry mouth, presents complex challenges for both medical and dental professionals, as it is not only an oral health concern but a systemic issue that affects overall health and quality of life. Xerostomia is characterized by a significant reduction or complete absence of salivary flow, and its causes are wide-ranging, including commonly prescribed medications such as antihistamines, decongestants, antihypertensives, and antidepressants, as well as systemic diseases like Sjögren’s Syndrome, diabetes, and autoimmune disorders. It is also frequently seen in patients undergoing cancer therapies, particularly head and neck radiation.
When left unaddressed, dry mouth can lead to rampant dental decay, gingivitis, periodontitis, mucosal irritation, difficulty speaking or swallowing, poor nutrition, and even sleep disruption. It affects millions of patients across multiple disciplines and is often underdiagnosed and undertreated. The systemic nature of xerostomia calls for an integrated solution that supports both symptom relief and long-term oral health.
At Orabio, we recognize this need and have developed Periovance Dry Mouth Gel. A non-prescription, FDA-cleared medical device that provides targeted relief and promotes oral wellness. With its proven ability to relieve dryness for up to six hours, Periovance helps bridge the gap between medicine and dentistry, empowering providers across specialties to improve the lives of patients struggling with this chronic condition.
.png)
